CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 30, 2013	Mar. 31, 2012
Cash flows from operating activities:
Consolidated net income	$ 77,958	$ 113,723
Adjustments to reconcile consolidated net income to net cash provided by (used for) operations:
Depreciation and amortization	31,505	29,050
Amortization of stock-based compensation	5,983	7,255
Equity in earnings of affiliated companies	(1,983)	(2,184)
Deferred income taxes	19,584	18,961
Restructuring, integration, and other charges	15,495	6,141
Excess tax benefits from stock-based compensation arrangements	(6,475)	(4,947)
Loss on prepayment of debt	2,627	0
Other	(1,031)	(1,457)
Change in assets and liabilities, net of effects of acquired businesses:
Accounts receivable	388,980	334,014
Inventories	(25,377)	(24,357)
Accounts payable	(467,797)	(135,198)
Accrued expenses	(173,437)	(64,564)
Other assets and liabilities	(45,436)	(26,102)
Net cash provided by (used for) operating activities	(179,404)	250,335
Cash flows from investing activities:
Cash consideration paid for acquired businesses	(9,382)	(160,543)
Acquisition of property, plant, and equipment	(26,751)	(22,253)
Other	(3,000)	0
Net cash used for investing activities	(39,133)	(182,796)
Cash flows from financing activities:
Change in short-term and other borrowings	(14,342)	(9,074)
Proceeds from long-term bank borrowings, net	44,300	329,700
Net proceeds from note offering	591,156	0
Redemption of senior notes	(338,184)	0
Proceeds from exercise of stock options	10,600	10,138
Excess tax benefits from stock-based compensation arrangements	6,475	4,947
Repurchases of common stock	(113,504)	(57,684)
Net cash provided by financing activities	186,501	278,027
Effect of exchange rate changes on cash	(13,497)	(2,745)
Net increase (decrease) in cash and cash equivalents	(45,533)	342,821
Cash and cash equivalents at beginning of period	409,684	396,887
Cash and cash equivalents at end of period	$ 364,151	$ 739,708